Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Management of in-stent restenosis in peripheral arteries: are DEBs sufficient as stand-alone treatment for femoro-popliteal in-stent restenosis?

Franzone A, Stabile E, Carbone A, Scudiero F, Trimarco B, Esposito G.

J Cardiovasc Surg (Torino). 2014 Jun;55(3):335-8. Review.

PMID:
24755701
[PubMed - indexed for MEDLINE]
2.

Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).

Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.

JACC Cardiovasc Interv. 2013 Dec;6(12):1295-302. doi: 10.1016/j.jcin.2013.07.010. Epub 2013 Nov 13.

PMID:
24239203
[PubMed - indexed for MEDLINE]
Free Article
3.

Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.

Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.

J Endovasc Ther. 2014 Feb;21(1):1-8. doi: 10.1583/13-4420R.1.

PMID:
24502477
[PubMed - indexed for MEDLINE]
4.

Femoropopliteal in-stent restenosis: current treatment strategies.

Singh GD, Armstrong EJ, Laird JR.

J Cardiovasc Surg (Torino). 2014 Jun;55(3):325-33. Review.

PMID:
24755700
[PubMed - indexed for MEDLINE]
5.

Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis.

Beschorner U, Zeller T.

J Cardiovasc Surg (Torino). 2014 Jun;55(3):347-9. Review.

PMID:
24755703
[PubMed - indexed for MEDLINE]
6.

Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.

Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Esposito G, Trimarco B, Rubino P.

JACC Cardiovasc Interv. 2014 Apr;7(4):411-5. doi: 10.1016/j.jcin.2013.11.020. Epub 2014 Mar 14.

PMID:
24630884
[PubMed - indexed for MEDLINE]
7.

Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.

Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, Kultgen PL, Rastan A.

JACC Cardiovasc Interv. 2013 Mar;6(3):274-81. doi: 10.1016/j.jcin.2012.12.118.

PMID:
23517839
[PubMed - indexed for MEDLINE]
Free Article
8.

The potential role of DES in peripheral in-stent restenosis.

Zeller T, Macharzina R, Tepe G.

J Cardiovasc Surg (Torino). 2010 Aug;51(4):561-5. Review.

PMID:
20671640
[PubMed - indexed for MEDLINE]
9.

Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.

Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E.

J Endovasc Ther. 2014 Jun;21(3):359-68. doi: 10.1583/13-4630MR.1.

PMID:
24915582
[PubMed - indexed for MEDLINE]
10.

Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention.

Armstrong EJ, Singh S, Singh GD, Yeo KK, Ludder S, Westin G, Anderson D, Dawson DL, Pevec WC, Laird JR.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1168-74. doi: 10.1002/ccd.24983. Epub 2013 Jun 3.

PMID:
23630047
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results.

Cioppa A, Stabile E, Popusoi G, Salemme L, Cota L, Pucciarelli A, Ambrosini V, Sorropago G, Tesorio T, Agresta A, Biamino G, Rubino P.

Cardiovasc Revasc Med. 2012 Jul-Aug;13(4):219-23. doi: 10.1016/j.carrev.2012.04.007. Epub 2012 May 25.

PMID:
22632996
[PubMed - indexed for MEDLINE]
12.

Pathophysiology of superficial femoral artery in-stent restenosis.

Yahagi K, Otsuka F, Sakakura K, Sanchez OD, Kutys R, Ladich E, Kolodgie FD, Virmani R, Joner M.

J Cardiovasc Surg (Torino). 2014 Jun;55(3):307-23. Review.

PMID:
24755699
[PubMed - indexed for MEDLINE]
13.

Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.

Karimi A, de Boer SW, van den Heuvel DA, Fioole B, Vroegindeweij D, Heyligers JM, Lohle PN, Elgersma O, Nolthenius RP, Vos JA, de Vries JP.

Trials. 2013 Mar 28;14:87. doi: 10.1186/1745-6215-14-87.

PMID:
23537403
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery.

Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T, Taylor P.

J Vasc Surg. 2014 Apr;59(4):1123-1133.e8. doi: 10.1016/j.jvs.2014.01.041. Review.

PMID:
24661896
[PubMed - indexed for MEDLINE]
15.

High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study.

Tepe G, Zeller T, Schnorr B, Claussen CD, Beschorner U, Brechtel K, Scheller B, Speck U.

J Endovasc Ther. 2013 Dec;20(6):792-800. doi: 10.1583/13-4392R.1.

PMID:
24325695
[PubMed - indexed for MEDLINE]
16.

Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial.

Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, Eschenbach G, Hartmann H, Lange C, Schnorr B, Stiepani H, Zoccai GB, Hänninen EL.

Circ Cardiovasc Interv. 2012 Dec;5(6):831-40. doi: 10.1161/CIRCINTERVENTIONS.112.971630. Epub 2012 Nov 27.

PMID:
23192918
[PubMed - indexed for MEDLINE]
Free Article
17.

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).

Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, Schultz GA, Scheinert D, Rocha-Singh KJ.

J Vasc Surg. 2013 Jul;58(1):73-83.e1. doi: 10.1016/j.jvs.2012.12.066. Epub 2013 May 2.

PMID:
23642924
[PubMed - indexed for MEDLINE]
Free Article
18.

2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.

Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A, Grattoni C, Pantaleo P, Cremonesi A, Rubino P, Biamino G.

JACC Cardiovasc Interv. 2013 Mar;6(3):282-9. doi: 10.1016/j.jcin.2013.01.128.

PMID:
23517840
[PubMed - indexed for MEDLINE]
Free Article
19.

The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.

Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K.

JACC Cardiovasc Interv. 2014 Jan;7(1):10-9. doi: 10.1016/j.jcin.2013.05.022.

PMID:
24456716
[PubMed - indexed for MEDLINE]
Free Article
20.

Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.

Fanelli F, Cannavale A, Boatta E, Corona M, Lucatelli P, Wlderk A, Cirelli C, Salvatori FM.

J Endovasc Ther. 2012 Oct;19(5):571-80. doi: 10.1583/JEVT-12-3926MR.1.

PMID:
23046320
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk